HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 31.4m in AUM and 67 holdings. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.
Franklin Genomic Advancements ETFïŒHELXïŒã®çŸåšã®äŸ¡æ Œã¯ãããã§ããïŒ
î
Franklin Genomic Advancements ETFïŒHELXïŒã®çŸåšäŸ¡æ Œã¯41.58ã§ããåžå ŽããŒã¿ã«ã¯é å»¶ãçããå ŽåããããããããŒãžäžã«è¡šç€ºãããŠããæŽæ°æ¥æããåç §ãã ããã
Franklin Genomic Advancements ETFã®52é±é«å€ã¯ãããã§ããïŒ
î
Franklin Genomic Advancements ETFã®52é±é«å€ã¯46.22ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
Franklin Genomic Advancements ETFã®52é±å®å€ã¯ãããã§ããïŒ
î
Franklin Genomic Advancements ETFã®52é±å®å€ã¯31.24ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
Franklin Genomic Advancements ETFã®NAVïŒçŽè³ç£äŸ¡å€ïŒã¯ãããã§ããïŒ